Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | US

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
ORGANIGRAM GLOBAL INC. Licensed producer of indoor-grown cannabis and derived products for medical & recreational consumers.	United States of America	OGI
Organon & Co. A global healthcare company focused on women's health, biosimilars, and established brands worldwide.	United States of America	OGN
Oric Pharmaceuticals, Inc. Developing therapies to overcome resistance in lung and prostate cancer.	United States of America	ORIC
Orion Oyj Develops and manufactures human/vet pharma, APIs, and generics for global markets.	Finland	ORNAV
Oruka Therapeutics, Inc. Develops long-acting antibody therapies for chronic inflammatory and skin diseases.	United States of America	ORKA
Orum Therapeutics, Inc. Developing degrader-antibody conjugates for cell-selective protein degradation to treat cancer.	South Korea	475830
OSR Holdings, Inc. Acquires biopharma R&D platforms to build a diverse portfolio of healthcare therapies.	United States of America	OSRH
OS Therapies Inc Developing a cancer vaccine to treat HER2-expressing tumors, primarily Osteosarcoma.	United States of America	OSTX
Otsuka Holdings Co., Ltd. Global healthcare group creating pharmaceuticals and nutraceuticals for worldwide well-being.	Japan	4578
Outlook Therapeutics, Inc. Developing an ophthalmic bevacizumab to treat retinal diseases like wet AMD.	United States of America	OTLK